Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder
Neuropsychiatric Disease and Treatment · 2023-09 · Volume 19 · 2027-2037
DOI: 10.2147/ndt.s423399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-09. Verfasst von Haiting Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Psychology and Psychiatric Department, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, People's Republic of China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychology and Psychiatric Department, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, People's Republic of China.
- Psychology and Psychiatric Department, Liaocheng People's Hospital, Liaocheng, People's Republic of China.
ORCID-Profile: Jingxu Chen
Zitieren
APA
Xu, H., Zheng, L., Wang, L., Gao, H., Wei, Y., & Chen, J. (2023). Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder. Neuropsychiatric Disease and Treatment, Volume 19, 2027-2037. https://doi.org/10.2147/ndt.s423399
Vancouver
Xu H, Zheng L, Wang L, Gao H, Wei Y, Chen J. Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder. Neuropsychiatric Disease and Treatment. 2023;Volume 19:2027-2037. doi:10.2147/ndt.s423399
BibTeX
@article{Xu2023,
author = {Xu, Haiting and Zheng, Lina and Wang, Leilei and Gao, Huanqin and Wei, Yanyan and Chen, Jingxu},
title = {Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder},
journal = {Neuropsychiatric Disease and Treatment},
year = {2023},
volume = {Volume 19},
pages = {2027--2037},
doi = {10.2147/ndt.s423399}
}
EUVIMED